ENVALITH
パス株式会社 logo

PATH corporation

3840Standard MarketInformation & Communication

パス株式会社 logo
PATH corporation3840

Governance

Company with an Audit and Supervisory Committee. The Board of Directors comprises 7 members in total: 4 internal directors and 3 independent outside directors (Audit and Supervisory Committee members). A voluntary Nomination and Compensation Committee has been established, with independent outside directors holding a majority.

Outside Director Ratio

42.9%

Nomination Committee

Established

Compensation Committee

Established

Risk Management

The Administration Department functions as the department in charge of centrally managing risk information. Company-wide risks, including sustainability and climate change risks, are identified using Enterprise Risk Management (ERM) methodology, and are reported on, deliberated, and evaluated at monthly management meetings held once a month, followed by one of the following responses: prevention, mitigation, transfer, or acceptance. The company has also established a system to utilize advice from external experts such as lawyers as needed.

Shareholder Returns

No dividend (annual dividend of ¥0) for FY2026 (ending March 2026). No dividend forecast for FY2027 (ending March 2027) either. The company has posted continuing operating losses and net losses, and is at a stage where rebuilding its financial foundation is the top priority. No mention of share buybacks.

Dividend Policy

The annual dividend for FY2026 (ending March 2026) is ¥0 (no dividend). The forecast for FY2027 (ending March 2027) is also ¥0 (no dividend). Having posted the largest loss since the company's founding, and amid the existence of material events regarding going concern assumptions, the company has not yet reached a stable accumulation of profits that would serve as a prerequisite for dividend payments. The policy is to prioritize the formulation of a new medium-term management plan and a fundamental restructuring of the profit structure.

Dividend

None

Share Buyback

None

Shareholder Benefits

None

ESG

Under the vision of "Beauty and health for people and the planet, 100 years from now," the company promotes its Sustainable Business through the development and sale of the microalgae-derived ingredient "Fucoxanthin" and CO2 reduction via Kagikenori (Cladophora) cultivation (the Kaginowa Project). As climate change targets, the company has set a 50% reduction in CO2 emissions (by 2030, versus a baseline of 11.5 tCO2e) and 100% sustainable cosmetics packaging and paper usage (by 2030). In terms of human capital, the company has set targets of 50% female managers and 30% female executives (both by 2030), and is implementing DE&I promotion, training programs, reskilling support, and other initiatives.

Last updated: June 25, 2026